Literature DB >> 23252941

Architecture of pharmacogenomic associations: structures with functional foundations or castles made of sand?

Dylan M Glubb, Federico Innocenti.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23252941      PMCID： PMC4128333          DOI： 10.2217/pgs.12.188

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN： 1462-2416            Impact factor:   2.533


× No keyword cloud information.
  27 in total

1.  Pooled association tests for rare variants in exon-resequencing studies.

Authors:  Alkes L Price; Gregory V Kryukov; Paul I W de Bakker; Shaun M Purcell; Jeff Staples; Lee-Jen Wei; Shamil R Sunyaev
Journal:  Am J Hum Genet       Date:  2010-05-13       Impact factor: 11.025

Review 2.  Mechanisms of genetic regulation in gene expression: examples from drug metabolizing enzymes and transporters.

Authors:  Dylan M Glubb; Federico Innocenti
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010-09-23

Review 3.  The use of genomic information to optimize cancer chemotherapy.

Authors:  Federico Innocenti; Nancy J Cox; M Eileen Dolan
Journal:  Semin Oncol       Date:  2011-04       Impact factor: 4.929

Review 4.  Integrative analysis of transcriptomic and proteomic data: challenges, solutions and applications.

Authors:  Lei Nie; Gang Wu; David E Culley; Johannes C M Scholten; Weiwen Zhang
Journal:  Crit Rev Biotechnol       Date:  2007 Apr-Jun       Impact factor: 8.429

5.  Potential etiologic and functional implications of genome-wide association loci for human diseases and traits.

Authors:  Lucia A Hindorff; Praveen Sethupathy; Heather A Junkins; Erin M Ramos; Jayashri P Mehta; Francis S Collins; Teri A Manolio
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-27       Impact factor: 11.205

Review 6.  Pharmacogenomic biomarkers: validation needed for both the molecular genetic mechanism and clinical effect.

Authors:  Wolfgang Sadee
Journal:  Pharmacogenomics       Date:  2011-05       Impact factor: 2.533

7.  Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS.

Authors:  Dan L Nicolae; Eric Gamazon; Wei Zhang; Shiwei Duan; M Eileen Dolan; Nancy J Cox
Journal:  PLoS Genet       Date:  2010-04-01       Impact factor: 5.917

8.  Regulatory polymorphism in vitamin K epoxide reductase complex subunit 1 (VKORC1) affects gene expression and warfarin dose requirement.

Authors:  Danxin Wang; Huizi Chen; Kathryn M Momary; Larisa H Cavallari; Julie A Johnson; Wolfgang Sadée
Journal:  Blood       Date:  2008-06-03       Impact factor: 22.113

9.  IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy.

Authors:  Vijayaprakash Suppiah; Max Moldovan; Golo Ahlenstiel; Thomas Berg; Martin Weltman; Maria Lorena Abate; Margaret Bassendine; Ulrich Spengler; Gregory J Dore; Elizabeth Powell; Stephen Riordan; David Sheridan; Antonina Smedile; Vincenzo Fragomeli; Tobias Müller; Melanie Bahlo; Graeme J Stewart; David R Booth; Jacob George
Journal:  Nat Genet       Date:  2009-09-13       Impact factor: 38.330

10.  An integrated encyclopedia of DNA elements in the human genome.

Authors: 
Journal:  Nature       Date:  2012-09-06       Impact factor: 49.962
View more
  2 in total

Review 1.  Implications of genome-wide association studies in cancer therapeutics.

Authors:  Jai N Patel; Howard L McLeod; Federico Innocenti
Journal:  Br J Clin Pharmacol       Date:  2013-09       Impact factor: 4.335

2.  Functional FLT1 Genetic Variation is a Prognostic Factor for Recurrence in Stage I-III Non-Small-Cell Lung Cancer.

Authors:  Dylan M Glubb; Laia Paré-Brunet; Eloisa Jantus-Lewintre; Chen Jiang; Daniel Crona; Amy S Etheridge; Osman Mirza; Wei Zhang; Eric L Seiser; Witold Rzyman; Jacek Jassem; Todd Auman; Fred R Hirsch; Kouros Owzar; Carlos Camps; Rafal Dziadziuszko; Federico Innocenti
Journal:  J Thorac Oncol       Date:  2015-07       Impact factor: 15.609
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.